WSGR logoWSGR logo
WSGR logo
  • Experience
  • People
  • Insights
  • About Us
  • Careers

  • Practice Areas
  • Industries

  • Corporate
  • Intellectual Property
  • Litigation
  • Patents and Innovations
  • Regulatory
  • Technology Transactions

  • Capital Markets
  • Corporate Governance
  • Corporate Life Sciences
  • Derivatives
  • Emerging Companies and Venture Capital
  • Employee Benefits and Compensation
  • Energy and Climate Solutions
  • Executive Advisory Program
  • Finance and Structured Finance
  • Fund Formation
  • Greater China
  • Mergers & Acquisitions
  • Private Equity
  • Public Company Representation
  • Real Estate
  • Restructuring
  • Shareholder Engagement and Activism
  • Tax
  • U.S. Expansion
  • Wealthtech

  • Special Purpose Acquisition Companies (SPACs)

  • Environmental, Social, and Governance

  • AI and Data Center Infrastructure
  • Energy Regulation and Competition
  • Project Development and M&A
  • Project Finance and Tax Credit Transactions
  • Sustainability and Decarbonization
  • Transportation Electrification

  • U.S. Expansion Library and Resources

  • Post-Grant Review
  • Trademark and Advertising

  • Antitrust Litigation
  • Arbitration
  • Board and Internal Investigations
  • Class Action Litigation
  • Commercial Litigation
  • Consumer Litigation
  • Corporate Governance Litigation
  • Employment Litigation
  • Executive Branch Updates
  • Government Investigations
  • Internet Strategy and Litigation
  • Patent Litigation
  • Securities Litigation
  • State Attorneys General
  • Supreme Court and Appellate Practice
  • Trade Secret Litigation
  • Trademark and Copyright Litigation
  • Trial
  • White Collar Crime

  • Advertising, Promotions, and Marketing
  • Antitrust and Competition
  • Committee on Foreign Investment in the U.S. (CFIUS)
  • Communications
  • Data, Privacy, and Cybersecurity
  • Export Control and Sanctions
  • FCPA and Anti-Corruption
  • FDA Regulatory, Healthcare, and Consumer Products
  • Federal Trade Commission
  • Fintech and Financial Services
  • Government Contracts
  • National Security and Trade
  • Payments
  • State Attorneys General
  • Strategic Risk and Crisis Management
  • Tariffs, Customs, and Import Compliance

  • Antitrust and Intellectual Property
  • Antitrust Civil Enforcement
  • Antitrust Compliance and Business Strategy
  • Antitrust Criminal Enforcement
  • Antitrust Litigation
  • Antitrust Merger Clearance
  • European Competition Law
  • Third-Party Merger and Non-Merger Antitrust Representation

  • Anti-Money Laundering
  • Foreign Ownership, Control, or Influence (FOCI)
  • Team Telecom

  • AI in Healthcare
  • Animal Health
  • Artificial Intelligence and Machine Learning
  • Aviation
  • Biotech
  • Blockchain and Cryptocurrency
  • Clean Energy
  • Climate and Clean Technologies
  • Communications and Networking
  • Consumer Products and Services
  • Data Storage and Cloud
  • Defense Tech
  • Diagnostics, Life Science Tools, and Deep Tech
  • Digital Health
  • Digital Media and Entertainment
  • Electronic Gaming
  • Fintech and Financial Services
  • FoodTech and AgTech
  • Global Generics
  • Internet
  • Life Sciences
  • Medical Devices
  • Mobile Devices
  • Mobility
  • NewSpace
  • Quantum Computing
  • Semiconductors
  • Software

  • Offices
  • Country Desks
  • Events
  • Community
  • Our Diversity
  • Sustainability
  • Our Values
  • Board of Directors
  • Management Team

  • Austin
  • Boston
  • Boulder
  • Brussels
  • Century City
  • Hong Kong
  • London
  • Los Angeles
  • New York
  • Palo Alto
  • Salt Lake City
  • San Diego
  • San Francisco
  • Seattle
  • Shanghai
  • Washington, D.C.
  • Wilmington, DE

  • Law Students
  • Judicial Clerks
  • Experienced Attorneys
  • Patent Agents
  • Business Professionals
  • Alternative Legal Careers
  • Contact Recruiting
Beyond Earth: The Future of Medicine and Biotechnology In Space
WSGR Events
Tuesday, October 29, 2024
9:00 - 10:30 AM PT

Virtual

Add to calendarView Recording

Join Wilson Sonsini and leading experts from ANYg Bio, BioOrbit, Frontier Space, ICE Cubes Service, Purdue University, Redwire Space, and SpacePharma for a virtual webinar exploring how medicine and biotechnology is being revolutionized in space and key considerations for companies in the sector.

ANYg Bio is engineering advanced biotech tools that work in any gravity to solve the problem of limited low-throughput bio-sample prep capabilities in Space. This single platform will be able to function seamlessly on Earth and in Space.

BioOrbit is aiming to be the go-to pharmaceuticals factory in microgravity, part of the space manufacturing revolution, currently developing a platform for large-scale crystallization of protein drugs.

Frontier Space is building the enabling technologies towards industrializing biotechnology in space for the benefit of life on Earth and beyond.

ICE Cubes Service by Space Applications Services is an end-to-end service launching your research and technology into space.

Purdue University is a world-renowned, public research university that advances discovers in science, technology, engineering, and math.

Redwire Space is accelerating humanity's expansion into space by delivering reliable, economical, and sustainable infrastructure for future generations.

SpacePharma is a global leader for biospace research and manufacturing of monoclonal antibodies. The company holds assets like research modules, small dose and mass production units in space. The Company granted an EIC-ACCELERATOR funding to prime the challenges of IV to SC for Europe on July 2024. SpacePharma holds patents on small molecules crystallization like monoclonal antibodies.

Contacts

Adam Pilkington

apilkington@wsgr.com

Presenters

Anjali Gupta, PhD
CEO & Co-Founder, ANYg Bio
View on LinkedIn
Katie King, PhD
CEO & Co-Founder, BioOrbit
View on LinkedIn
Aqeel Shamsul, PhD
CEO & Co-Founder, Frontier Space
View on LinkedIn
Miguel J. S. Ferreira, PhD
Business Development, ICE Cubes Service
View on LinkedIn
Rainer Fischer, PhD
Professor & Advisor, Purdue University
View on LinkedIn
Ken Savin, PhD
Chief Scientist, Redwire Space
View on LinkedIn
Yossi Yamin
CEO & Co-Founder, SpacePharma
View on LinkedIn
  • people
  • insights
  • about us
  • careers
  • Binder
  • Alumni
  • Mailing List Signup
  • Client FTP Portal
  • Privacy Policy
  • Terms of Use
  • Accessibility
WSGR logo
Twitter
LinkedIn
Facebook
Instagram
Youtube
Copyright © 2026 Wilson Sonsini Goodrich & Rosati. All Rights Reserved.